Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
START: Buprenorphine/Naloxone vs Methadone for Hepatic Safety
NCT00315341Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Apr 2006
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by University of California, Los Angeles. Started Apr 2006; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00315341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315341.